drugset / Trial / NCT06034197
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine the safety and feasibility of VGT-309 for the visualization of colorectal tumors in real-time using near-infrared (NIR) fluorescence endoscopy. In addition, signatures of 50+ biomarkers will be evaluated in biopsies using CODEX multi-plexing.
Timeline
- Start
- 2024-02-07
- Primary completion
- 2025-04-04
- Completion
- 2025-04-04
Outcome
Outcome not reported
Stopped: “The drug supply expired and the sponsor is unable to provide an updated supply.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abenacianine | Diagnostic / imaging agent | 0.32 mg/kg | Intravenous |